What is Bodd?
Bodd operates at the intersection of advanced imaging and data analytics, providing sophisticated 3D body scanning technology. The company's core competency lies in its ability to collect detailed human body data, which is then leveraged for applications across commercial and healthcare sectors. This data-driven approach enables Bodd to offer precise insights and solutions tailored to diverse market needs, from consumer applications to medical diagnostics and personalized product design.
How much funding has Bodd raised?
Bodd has raised a total of $14.9M across 2 funding rounds:
Other Financing Round
$5M
Other Financing Round
$9.9M
Other Financing Round (2022): $5M with participation from Candace Hirons, Nick Hirons, and Tim Allison
Other Financing Round (2025): $9.9M led by Blue Sky Capital and Ellerston Capital
Key Investors in Bodd
Blue Sky Capital
Blue Sky Capital Corporation is a private investment firm that focuses on high-potential teams, technologies, and business models, particularly in mobile and security-related technologies for the financial services and payment sectors. The firm is led by a team of experienced entrepreneurs and investment professionals who enhance their partnerships.
Ellerston Capital
Ellerston Capital, founded in 2002 and based in Australia, is a specialist investment management firm providing innovative equity and alternative investment strategies. The company offers a diverse range of investment products including Australian, global, and Asian equities, market neutral strategies, discretionary global macro, global long-short equity, and private equity investments.
What's next for Bodd?
With the recent major enterprise-level funding and strategic investment, Bodd is positioned for substantial growth. The company's focus on international expansion suggests an ambition to capture global market share, while the emphasis on product development indicates a commitment to enhancing its technological capabilities and service offerings. This strategic backing will likely fuel further innovation in 3D body scanning, potentially leading to new applications and deeper market penetration in the healthcare and commercial industries.
See full Bodd company page